title: Cellular mechanism of angiotensin II-induced atrial natriuretic peptide release in rat right atrial tissue.
abstract: This study presents an investigation of the mechanism of angiotensin II (Ang II)-induced atrial natriuretic peptide (ANP) release in superfused sliced right atria of rats. Ang II (0.1 microM) enhanced ANP release by 49%. This phenomenon was significantly blocked by (Sara1-Ileu 8) Ang II (1 microM) and losartan (0.1 microM). The use of neomycin (100 microM), a phospholipase-C inhibitor completely suppressed the effect of Ang II on ANP increase. To elucidate the intracellular mechanism of ANP released by Ang II, the role of protein kinase C (PKC) was determined by 1-(5-isoquinolinesulfonyl)-2-methylpiperazine (H-7) and phorbol ester : 4-beta-phorbol 12-myristate-13-acetate (PMA). We observed that PMA (0.1 microM) stimulated ANP release whereas H-7 (10 microM), an inhibitor of PKC in the presence of Ang II, prevented ANP increase. The role of calcium was also evaluated with 8-(N-N-diethylamino)-ocytyl-3,4,5, trimethoxy-benzoate (TMB-8) (10 microM) and N-(6-aminohexyl)-5-chloro-1-naphtalene sulfonamide (W-7) (10 microM), which completely inhibited ANP release by Ang II. Pre-treatment with diltiazem (10 microM), an antagonist of the Ca++ channel, did not prevent ANP increase due to Ang II, but A23187 (5 microM) enhanced ANP release by Ang II. These results suggest that PKC and intracellular calcium play an important role in ANP release under the influence of Ang II in rat atrial tissue.
authors.affiliation: Service de biochimie médicale, CHU Pitié-Salpêtrière, Paris.
authors.forename: H
authors.initials: H
authors.lastname: Soualmia
authors.forename: F
authors.initials: F
authors.lastname: Masson
authors.forename: C
authors.initials: C
authors.lastname: Barthélemy
authors.forename: G
authors.initials: G
authors.lastname: Maistre
authors.forename: A
authors.initials: A
authors.lastname: Carayon
mesh_terms: D015059:1-Sarcosine-8-Isoleucine Angiotensin II / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000378:metabolism*; D001713:Biphenyl Compounds / Q000494:pharmacology; D002118:Calcium / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism; D002852:Chromatography, Ion Exchange; D006325:Heart Atria / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D019808:Losartan; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013777:Tetrazoles / Q000494:pharmacology
chemical_list: D001713:Biphenyl Compounds; D007093:Imidazoles; D013777:Tetrazoles; D000804:Angiotensin II; D009320:Atrial Natriuretic Factor; D015059:1-Sarcosine-8-Isoleucine Angiotensin II; D011493:Protein Kinase C; D019808:Losartan; D002118:Calcium